This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals (MAP)

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00870792
First received: March 26, 2009
Last updated: January 10, 2017
Last verified: March 2009
March 26, 2009
January 10, 2017
November 2002
January 2005   (Final data collection date for primary outcome measure)
Antiretroviral medication adherence as assessed by electronic pill cap monitoring. [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT00870792 on ClinicalTrials.gov Archive Site
Self-reported medication adherence [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
We hypothesized that providing physicians treating with HIV disease, at the time of a routine outpatient visit, with a detailed report describing patients' adherence with HIV antiretroviral medications, would improve the quality of the physician-patient interaction, and also patients' subsequent adherence.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Health Services Research
  • HIV Infection
  • HIV Infections
Behavioral: Adherence report
During the intervention phase, the data collected at the study visit were summarized in a 3-page report that was given to the provider before each intervention visit. The report included data on self-reported adherence, MEMS adherence, reminder use, beliefs about ART, reasons for missed doses, alcohol and drug use, and depression.
  • Active Comparator: Received report
    Intervention: Behavioral: Adherence report
  • Placebo Comparator: Routine care
    Patients receive usual, routine, care.
    Intervention: Behavioral: Adherence report

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
156
February 2005
January 2005   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • on ART
  • willing to use MEMS cap
  • speaks and reads English
  • detectable viral loads

Exclusion Criteria:

  • uses a pill box
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00870792
ibwadhrct88$
No
Not Provided
Not Provided
Not Provided
Ira B. Wilson, MD, MSc, Tufte Medical Center
National Institute on Drug Abuse (NIDA)
Not Provided
Principal Investigator: Ira B. Wilson, MD Tufts Medical Center
National Institute on Drug Abuse (NIDA)
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP